Navigation Links
2-D MARKER from Pierce Biotechnology, Inc.

Products2-D MARKER from Pierce Biotechnology, Inc.
Company Pierce Biotechnology, Inc.
Item 2-D MARKER
Price 
Description The new Pierce ready-to-use 2-D gel marker mix was designed specifically to aid the proteome analyst. This 2-D gel marker mix contains a complement of seven reduced and denatured proteins that offer important features of value to those who use markers to assess 2-D system performance or estimate pI and molecular weight values of proteins undergoing 2-D separation and analysis.

A unique complement of proteins

Each protein in this marker mix was carefully selected to give a useful range of molecular weight and pI coverage. Proteins were selected that give a variety of features from tight single spots to characteristic charge trains to aid the analyst in gel orientation. Molecular weights range from 17K to 80K, with pI values ranging from 4.5 to 8.7.

Info Pierce Biotechnology, Inc.Pierce Biotechnology, Inc.
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117
Rockford, IL 61105
Customer Service: 815-968-0747
Fax Number: 815-968-8148
Web Site: http://www.piercenet.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Modern Protein Chemistry: Practical Aspects from Pierce Biotechnology, Inc.
2. Protein-Protein Interactions, from Pierce Biotechnology, Inc.
3. Imject Freunds Complete Adjuvant (FCA) from Pierce Biotechnology, Inc.
4. Imject Freunds Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
5. Extracti-Gel D Detergent Removing Gel AffinityPak Columns from Pierce Biotechnology, Inc.
6. GUIDE TO PROTEIN PURIFICA from Pierce Biotechnology, Inc.
7. PROTEIN PROTOCOLS Book from Pierce Biotechnology, Inc.
8. Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
9. UltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.
10. DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.
11. PATH Protein Microarray Kit from Pierce Biotechnology, Inc.
Propidium Iodide Buffer from BioLegend
Mouse Anti-Escherichia coli Lac1 Monoclonal Antibody, Unconjugated, Clone 0.T.81 from Abcam
Goat Anti-Human HADHB Polyclonal Antibody, Unconjugated from IMGENEX
EDG-6 Lysate from Exalpha Biologicals, Inc.
Biology Products:
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In a...he bugs, they have natural enemies called bacterio...th every two days. , Still, bacteria and anothe...scovered in extreme environments such as deep-sea ...rt because they have a built-in defense system tha...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 1CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 1Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 2
...quences from tiny green algae have provided new in...kton evolve—and further highlights their critical ...ese findings, by a group led by the DOE Joint Geno... Oceanography, University of California, San Diego...e published this week in the Proceedings of the Na...
... potentially assist cancer diagnosis, a new optica...ional images of blood vessels by taking advantage ...s of hemoglobin, the red-blood-cell molecule that ...earch will be presented in Baltimore at CLEO/QELS,...loped at Duke University, should provide 3-D image...
... Institute for Biological Studies have identified ...in healthy muscle and restores normal muscle funct...es. The study, published online in Nature Medicine...ys in a cascade of events triggered by exercise-in...cular pathway, a molecular switch turns on a set o...
Other Biology News:Puzzling plankton yield secrets to role in evolution/global photosynthesis 2Puzzling plankton yield secrets to role in evolution/global photosynthesis 3Catching cancer's spread by watching hemoglobin 2Catching cancer's spread by watching hemoglobin 3Salk scientists hammer out a pathway that promotes muscle cell survival in mice 2
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
(Date:11/24/2009)... 24 Sigma-Aldrich Corpor...ASDAQ OMX conference on Tuesday, December 1st at 1...arties may listen via live audio broadcast over th... m a a ldrich.com/ . Users can click the "Web...gma-Aldrich: Sigma-Aldrich is a leading Life Sci...
(Date:11/24/2009)...if., Nov. 24 NeurogesX, ... focused on developing and commercializing novel p...hony DiTonno, President and Chief Executive Office...r Jaffray Health Care Conference, to be held Decem...York, New York. ,, Mr. DiTonno and Stephen Ghi...
(Date:11/24/2009)...cacy endpoint has been met for patients with advan..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - ...the "Company"), a global biopharmaceutical company...announced positive efficacy data from a Phase 2 st... AEZS-108 (formerly AN-152), in patients with adva...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4